somatropin (rDNA origin), A biosimilar growth hormone replacement therapy available in both vial and pen delivery systems, offering patients flexible treatment options.
OMNITROPE® is the first FDA-approved biosimilar somatropin, manufactured by Sandoz. It is indicated for multiple growth disorders in children and adults, and is available in both vial formulations for reconstitution and convenient pre-filled pen systems.
Our bilingual support team can assist patients in both English and Spanish with enrollment and medication guidance.